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Objective: To compare the visual outcomes and central retinal thickness (CRT) 1 week, 2 weeks, and 4
weeks after surgery in diabetic patients without retinopathy and nondiabetic patients. The relationships
between glycated hemoglobin (HbA1c) and visual outcomes and changes in CRT were also evaluated.
Methods: Patients who underwent uncomplicated phacoemulsiﬁcation cataract surgery were enrolled
from May 2009 to December 2010, excluding those with preoperative retinal diseases. CRT and best-
corrected visual acuity were obtained preoperatively and at 1 week, 2 weeks, and 4 weeks.
Results: There were 101 eyes in the nondiabetic group and 58 eyes in the diabetic without retinopathy
group. There was no difference in preoperative CRT between the two groups. A signiﬁcant increase in
thickness was observed at postoperative Week 4 (p < 0.001) in both groups. However, there were no
signiﬁcant differences in CRT and best-corrected visual acuity before surgery and in all postoperative
periods between the groups. In the diabetic without retinopathy group, CRT and visual outcomes were
not statistically related to HbA1c level at any time point.
Conclusion: There were no signiﬁcant differences in improvements in postphacoemulsiﬁcation CRT and
visual outcomes between the groups. In the diabetic without retinopathy group, the visual outcomes and
CRT were not related to the level of HbA1c. Therefore, as long as there is no diabetic retinopathy, the early
postoperative visual recovery and central retinal thickness may not be different from patients without
diabetes mellitus.
Copyright  2014, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Macular edema is a well-known complication after cataract
surgery.1e4 Even uncomplicated cataract surgery may induce
postsurgical inﬂammation and vitreous instability that may sub-
sequently cause postoperative macular edema in normal in-
dividuals.5 When the post cataract macular edema is associated
with a decrease in visual acuity, it can be categorized as clinical
pseudophakic cystoid macular edema. It usually appears as ar proprietary interest in any
ology, Shin Kong Wu Ho-Su
ih-Lin District, Taipei 11120,
.-K. Cheng).
ciety of Taiwan. Published by Elsepetaloid pattern of leakage in ﬂuorescein angiography, and has
been referred to as IrvineeGass syndrome.6,7 Clinical cystoid
macular edema (CME) is not frequently encountered with a re-
ported incidence after phacoemulsiﬁcation of 0.1e2% in healthy
participants.3e5 However, angiographic macular leakage is more
commonly detected in patients who do not have visual impairment.
This is referred to as subclinical macular edema, with a reported
incidence of 9e19% after uncomplicated phacoemulsiﬁcation.1,2
Diabetic retinopathy has long been implicated as a risk factor for
more prominent postoperative macular edema and poorer visual
outcomes.8e15 In eyes with diabetic retinopathy, the blooderetina
barrier is often impaired to a variable degree, which may cause the
eyes to be more prone to develop postoperative macular edema.
Depending on the disease severity, duration, presence of
pre-existing macular edema, and previous treatment with pan-
retinal photocoagulation or macular laser, the incidence ofvier Taiwan LLC. All rights reserved.
Table 1
Demographic data.
Nondiabetic Diabetic without
retinopathy
p
Number of patients 101 58
Men 59 44.83 0.64
Age (y) 68.91  10.68 66.09  9.84 0.09
OD 58 59 0.94
Preoperative BCVA (logMAR) 0.78  0.45 0.67  0.44 0.15
Preoperative CRT (mm) 200.30  22.81 200.74  27.68 0.93
Data are presented as mean  SD or %, unless otherwise indicated.
BCVA ¼ best-corrected visual acuity; CRT ¼ central retinal thickness;
logMAR ¼ logarithm of minimal angle resolution; OD ¼ right eye.
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been reported to range from 31% to 81%,8e10 which is much higher
than the incidence of postphacoemulsiﬁcation in nondiabetic pa-
tients. However, whether diabetes mellitus without retinopathy is
also a risk factor for macular edema has still not been adequately
discussed.16,17 In the present study,weevaluated changes in CRTand
visual outcomes in diabetic patients without retinopathy and in
nondiabetic controls at the preoperative examination and 1week, 2
weeks, and 4 weeks after small-incision clear-corneal phacoemul-
siﬁcation. For quantitative comparisons, we used optical coherence
tomography (OCT) to measure macular thickness. To further eval-
uate the relationship of recent treatment to control diabetes and the
degree of postoperative edema, we also compared the preoperative
glycated hemoglobin (HbA1c) level and the increase in macular
thickness in the diabetic without retinopathy group.
2. Methods
2.1. Participants
This is a retrospective chart review of 358 eyes that received
phacoemulsiﬁcation and intraocular lens insertion by one of the au-
thors (C.K.C.) fromMay 2009 to December 2010 at Shin KongWuHo-
Su Memorial Hospital, Taipei, Taiwan. Detailed medical/ocular his-
tories were recorded for all of the patients, and all patients initially
received ocular examinations including tonometry, slit-lamp exami-
nations of the anterior segment, and dilated retinal biomicroscopy.
Best-corrected visual acuity (BCVA)was checked by Snellen chart and
presented as logarithm of minimal angle resolution (logMAR). OCT
(Stratus III; Carl Zeiss, Dublin, CA, USA) was performed during each
visit. CRT was obtained using six diagonal, 6-mm radial line scans,
with the manufacturer’s macular thickness map software (version
4.0). The mean retinal thickness of the central 1-mm-diameter area
was recorded for analysis. All examinations were performed preop-
eratively, and then 1 week, 2 weeks, and 4 weeks after the surgery.
The inclusion criteria were patients who: (1) had uneventful
surgery; (2) followed the scheduled postoperative examinations at
postoperative Day 1, Week 1, Week 2, and Week 4; and (3) had a
reliable medical history of having or not having diabetes mellitus
within 3 months prior to the operation. Excluded were patients
who: (1) had documented diabetic retinopathy, preoperative
macular edema, previous intraocular surgery, and other ocular
diseases such as macular hole, epiretinal membrane, retinal
detachment, retinal vein occlusion, retinal artery occlusion, age-
related macular degeneration, optic neuritis, and other macular
diseases according to their medical/ocular history or preoperative
examinations by preoperative dilated retinal biomicroscopy, OCT,
and/or ﬂuorescein angiography; and (2) did not have clear preop-
erative or postoperative OCT documentation. In total, 58 eyes in 58
patients with type II diabetes mellitus without diabetic retinopathy
(diabetic without retinopathy group), and 101 eyes of 101 nondia-
betic patients (control group) were included in this study. The
study was conducted in accordance with the guidelines of the
Declaration of Helsinki. No approval of the institute review board
was required for this chart review retrospective study.
2.2. Surgical procedures
All of the eyes included in this study received uncomplicated
phacoemulsiﬁcation cataract extraction surgery by one experi-
enced surgeon. All patients signed an informed consent for
receiving the operation. The operation was done under topical
anesthesia and topical povidone iodine disinfection. A clear cornea
small-incision, capsulorhexis, phacoemulsiﬁcation, and implanta-
tion of a foldable acrylic posterior chamber intraocular lens wereperformed. Postoperatively, topical prednisolone 1.0% and antibi-
otics were prescribed for 1 week.
2.3. Statistical methods
Analyses were performed using SPSS version 17.0 (SPSS Inc,
Chicago, IL, USA). LogMAR was used to compare the BCVA between
two groups by the ManneWhitney U test. The pre- and post-
operative intraindividual differences were analyzedwith the paired
sample t test, and the independent t test was used when comparing
central retinal thickness between the groups. Statistical signiﬁ-
cance was deﬁned as p < 0.05.
3. Results
3.1. Demographic data
Fifty-eight eyes of diabetic patients and 101 eyes of control
patients that fulﬁlled the inclusion and exclusion criteria were
enrolled in this study. The average age of the patients was 67.11
years, and 54.1% were male. The demographic data of both groups
are shown in Table 1. There were no differences in age, sex, later-
ality, initial BCVA, and baseline CRT between the groups.
3.2. Postoperative CRT changes
Box plots of differences between post- and preoperative CRT in
both groups are depicted in Figs. 1 and 2, respectively. In the
nondiabetic group, there was a statistically signiﬁcant increase in
CRT at postoperative Week 2 (p ¼ 0.04), and postoperative Week 4
(p < 0.001; Fig. 1). In the diabetic without retinopathy group, the
CRT at postoperative Week 4 increased signiﬁcantly compared to
the baseline value (p < 0.001; Fig. 2).
Table 2 shows the comparison of pre- and postoperative CRT be-
tweenbothgroups. Therewereno signiﬁcantdifferences inmeanCRT
between the groups preoperatively (p ¼ 0.93) and at postoperative
Week 1 (p ¼ 0.79), Week 2 (p ¼ 0.62), and Week 4 (p ¼ 0.20).
3.3. Postoperative visual outcomes
To compare the visual outcomes between the groups, the BCVA
in logMAR was used. As expected, there were signiﬁcant im-
provements in BCVA at all postoperative examination time periods.
However, there was no signiﬁcant difference in median BCVA be-
tween the groups preoperatively (p ¼ 0.15) and at postoperative
Week 1 (p ¼ 0.52), Week 2 (p ¼ 0.12), and Week 4 (p ¼ 0.14; Fig. 3).
3.4. Correlation between HbA1c and CRT and visual outcome in the
diabetic without retinopathy group
The relationship between CRT and HbA1c is shown in Fig. 4.
There was no statistically signiﬁcant correlation between CRT and
Fig. 1. Box plots of differences between postoperative central retinal thickness (CRT)
and preoperative CRT in the nondiabetic group. The percent change in CRT is shown as
lines (mean  standard deviation). There is a statistically signiﬁcant increase in CRT at
postoperative Week 2 (p ¼ 0.04), and postoperative Week 4 (p < 0.001). (The mean
value of CRT is labeled on the box with the unit as mm.)
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(p ¼ 0.15), and Week 4 (p ¼ 0.54). In addition, there was no sta-
tistically signiﬁcant correlation between BCVA in logMAR and
HbA1c preoperatively (p ¼ 0.58), and at Week 1 (p ¼ 0.39), Week 2
(p ¼ 0.94), and Week 4 (p ¼ 0.91; Fig. 5).4. Discussion
In the present study, we evaluated changes in CRT and visual
outcomes in diabetic patients without retinopathy and in nondia-
betic controls. The results revealed that an increase in CRT wasFig. 2. Box plots of differences between postoperative central retinal thickness (CRT)
and preoperative CRT in the diabetic without retinopathy group. There is a statistically
signiﬁcant increase in CRT at postoperativeWeek 4 (p< 0.001). (The mean value of CRT
is labeled on the box with the unit as mm.)foundwithin 4weeks postoperatively in both groups (Figs.1 and 2).
In both groups, the CRT gradually increased after cataract surgery
frompostoperativeWeek 1, and had increased signiﬁcantly atWeek
4. However, the visual acuity did not deteriorate as the CRT
increased at any postoperative time point. When we compared the
CRT between the groups, there was no statistically signiﬁcant dif-
ference at any postoperative examination time point (Table 2). Our
results also revealed that there was no signiﬁcant difference in
visual outcome between the groups at any postoperative time point
up to 4 weeks, which also suggests that diabetes per se without
diabetic retinopathy did not seem to signiﬁcantly inﬂuence the
visual outcomes in the short-term postoperative period.18
We also evaluated the relationship between HbA1c in post-
operative OCT change and visual outcomes in the diabetic without
retinopathy group. To the best of our knowledge, this has rarely
been reported in the literature. HbA1c is regarded as a marker for
average blood glucose levels over the previous several months prior
to the measurement. In the current study, the HbA1c level was not
found to be correlated with the postoperative macular thickness
and visual outcome at any postoperative examination time point up
to 4 weeks (Figs. 4 and 5). This implies that the average level of
blood glucose in a limited time period (several months) prior to
phacoemulsiﬁcation surgerymay not be a major risk for short-term
postoperative macular edema in diabetic eyes as long as there is no
diabetic retinopathy. However, this lack of correlation of HbA1c and
postoperative macular edema may not be applied to eyes with
diabetic retinopathy, because a correlation of HbA1c and progres-
sion of macular edema after phacoemulsiﬁcation in eyes with
diabetic retinopathy for as long as 12 months has been reported.19
Many authors have reported guarded visual outcomes after
cataract surgery in patients with diabetic retinopathy, particular in
those patients with pre-existing diabetic macular edema or a long
history of retinopathy.8,9,11e13 However, advances in techniques
from the less vitreous-stable systems of intracapsular or extrac-
apsular cataract extraction to the more vitreous-stable systems of
small-incision phacoemulsiﬁcation have improved the post-
operative structure and visual outcomes in patients with diabetic
retinopathy.3,20,21 Recently, Eriksson et al15 conducted a study using
ﬂuorescein angiography (FA) and OCT to compare postoperative
macular edema and visual outcomes for 6 months between eyes
with mild to moderate diabetic retinopathy and normal individuals
after small-incision phacoemulsiﬁcation and foldable posterior
chamber intraocular lens insertion, and found a signiﬁcant
improvement in both groups after cataract surgery. Although there
was a larger percentage of ﬂuorescein leakage on FA in the eyes
with diabetic retinopathy than the normal controls (76% vs. 23%,
respectively), they failed to ﬁnd a signiﬁcant difference in central
macular thickness increase at any postoperative examinations for
up to 6 months. Instead, they found that the outer parafoveal
macular thickness and total macular volume were signiﬁcantly
thicker in diabetic retinopathy at postoperative Week 6, and in
addition, the median BCVA was signiﬁcantly different between the
groups only at this time point. Other studies, however, have re-
ported that phacoemulsiﬁcationmay inﬂuence the improvement inTable 2
Comparison of preoperative and postoperative central retinal thickness (mm) be-
tween the control and diabetic groups.
Nondiabetic
(n ¼ 101)
Diabetic without
retinopathy (n ¼ 58)
p
Preoperative 200.30  22.81 200.74  27.68 0.93
Postoperative Week 1 202.16  26.23 203.40  23.83 0.79
Postoperative Week 2 203.58  25.26 205.69  24.73 0.62
Postoperative Week 4 207.98  26.99 214.29  29.28 0.20
Data are presented as mean  SD.
Fig. 3. Box plots of best corrected visual acuity (BCVA) in logarithm of minimal angle resolution (LogMAR) comparing the nondiabetic group (solid black boxes) and diabetic without
retinopathy group (striped boxes) preoperatively, at Week 1, Week 2, and at Week 4. Median visual acuity is drawn as lines. The boxes include interquartile range (25e75% of
observations). There was no signiﬁcant difference in median visual acuity between the groups preoperatively (p¼ 0.15), at Week 1 (p¼ 0.52), Week 2 (p¼ 0.12), or Week 4 (p¼ 0.14;
ManneWhitney U test).
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on the pre-existing condition of maculopathy and severity of
retinopathy.21,22
In eyes with diabetic retinopathy, hyperglycemia induces
endothelial dysfunction, pericyte loss, increase of angiogenic
growth factors, and platelet and blood viscosity abnormalities to
create a microenvironment that may be more susceptible to cata-
ract surgery-induced macular edema.23e25 A similar microenvi-
ronment susceptibility to cataract surgery may also exist in diabetic
patients without retinopathy, but to a lesser extent. Hayashi et al19
reported a substantially increased mean foveal thickness as
detected by OCT at 3 months postoperatively in diabetic eyes with
retinopathy compared to diabetic eyes without retinopathy (23% vs.
6%, respectively). Kim et al23 reported that both postoperative
macular edema and visual outcomes were signiﬁcantly worse in
the diabetic retinopathy group than in the nondiabetic retinopathy
group after cataract surgery. Similar to our study, they found that
the mean central foveal thickness of diabetic eyes without reti-
nopathy increased by only a very small amount in the short-term
postoperative periods (18 mm and 14 mm at 1 month and 3
months after phacoemulsiﬁcation, respectively), whereas the mean
central foveal thickness in eyes with mild to moderate non-
proliferative diabetic retinopathy increased by a far greater amount
at the same time periods (127 mm and 117 mm at 1 month and 3
months, respectively). The more prominent increase in macular
thickness was also associated with a lesser improvement in post-
operative visual outcomes in diabetic retinopathy eyes. These
studies suggest that diabetic eyes with or without retinopathy
respond very differently in postoperative structure and visual
function after cataract surgery. Preoperative identiﬁcation of
whether or not the patients have diabetic retinopathy is thus an
important prognostic factor in the evaluation of the expected ef-
fects of cataract surgery.
Degenring et al24 conducted a study similar to ours, and
compared the postphacoemulsiﬁcation macular changes and visual
outcomes between diabetic and nondiabetic eyes for 4 weeks after
cataract surgery. Although they did not ﬁnd a signiﬁcant difference
in macular thickness on OCT between the groups preoperatively
and all time points postoperatively, they did ﬁnd a trend toward a
more prominent increase in foveal thickness in the diabetic eyesthan the nondiabetic eyes at postoperative Week 4 (p ¼ 0.058).
However, unlike our study, they found signiﬁcant worse visual
outcomes at the postoperative Week 4 examination in the diabetic
group than in the nondiabetic group (p ¼ 0.001). This discrepancy
in visual outcome may be due to the differences in the criteria for
patient selection. In our study, any patient with clinically detectable
retinopathy was excluded from entering the study, whereas in
Degenring et al’s study,24 25% of the eyes in the diabetic group had
various degrees of diabetic retinopathy (2 had nonproliferative
retinopathy, 2 had been treated with panretinal photocoagulation,
and 2 had both panretinal photocoagulation and macular laser
therapy). Because patients with diabetic retinopathy are more
prone to have a less satisfactory visual outcomes after cataract
surgery, including eyes with retinopathy may therefore inﬂuence
the visual outcomes in the diabetic group.
Very few studies have focused on comparisons of the outcomes
of postcataract surgery between diabetic eyes without retinopathy
and nondiabetic eyes as in our study. Menchini et al16 conducted a
study in 1993 comparing the incidence of CME after extracapsular
cataract extraction and intraocular lens implantation in diabetic
patients without retinopathy and nondiabetic patients. They found
a similar frequency of angiographic CME in the two groups 30 days
after surgery, but a signiﬁcantly higher frequency in the diabetic
eyes at 90 days,180 days, and 360 days. Final visual acuity, however,
was similar in both groups. This suggests that, similar to our study,
even with the older cataract surgical technique of extracapsular
cataract extraction, the short-term macular structure and visual
changes were not different between the patients with diabetes
without retinopathy and the normal controls. Kim et al23 also found
only minimal increases in mean central macular thickness in pa-
tients with diabetes without retinopathy at 1 month and 3 months
postphacoemulsiﬁcation. The results of another study conducted
by Katsimpris et al17 in 2012, were, however, very different from
our results and the studies of Menchini el al16 and Kim et al.23
Instead, they found a signiﬁcant post-phacoemulsiﬁcation in-
crease (48e78 mm) in CRT from 1 month to 12 months post-
operatively in the diabetic without retinopathy eyes compared to
the normal controls.17 In their study, the authors implied that the
more prominent increase in postoperative CRT may account for the
less satisfactory visual results following cataract surgery in the
Fig. 4. Linear regression showed no statistically signiﬁcant correlation between central retinal thickness (CRT) and glycated hemoglobin (HbA1c) preoperatively (p ¼ 0.49), at Week
1 (p ¼ 0.72), Week 2 (p ¼ 0.15), and Week 4 (p ¼ 0.54).
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difﬁcult to deduce why their diabetic without retinopathy patients
encountered such poor results in postoperative macular edema, as
many conditions during or after the operationmay affect the results
of cataract surgery.3 However, according to Eriksson et al,15 even in
eyes with diabetic retinopathy, the OCT ﬁnding of macular change
and the inferiority of visual outcome may only be transient in the
short-term (6 weeks) postphacoemulsiﬁcation period.
We used OCT for the measurement of macular thickness prior to
and after cataract surgery. In the past, only qualitative or semi-
quantitative measurements of macular thickening by either bio-
microscopy examinations or FA could be used for the detection of
macular thickness. OCT provides a more detailed qualitative ex-
amination of macular morphology, and also precise and linear
quantitative measurements of macular thickness. However, there
has been some controversy regarding whether postoperative
macular thickening signiﬁcantly correlates with postoperative vi-
sual outcomes after cataract surgery in normal individuals. One
author found a correlation between VA and macular thickness25
whereas others have not.15,26,27 Kim et al18 reported that thereseemed to be a threshold of postcataract surgery macular thick-
ening associated with clinically impaired visual outcomes. An in-
crease of 40% or more in macular thickness18 or a morphological
IrvineeGass pattern of cystic changes as detected by OCT15 could be
regarded as a threshold for reporting clinical vision-relevant post-
cataract macular edema. In our study, there was no difference in
median macular thickness between the groups, and no cases in
either group had an increase in macular thickness to reach this
threshold. We thus believe that the increases in macular thickness
in all of our cases could only be regarded as subclinical changes.
The limitations to this study include the retrospective nature
and the smaller number of patients in the diabetic without reti-
nopathy group. The use of time domain OCT instead of the more
recent spectral domain of OCT is also a drawback, because a
detailed morphological analysis may therefore not be possible.
Another major limitation is that we did not investigate the longer-
term macular changes and the visual results. As mentioned above,
there is some controversy over the duration of the macular changes
between diabetic without retinopathy eyes and nondiabetic eyes.
There is a need for longer-term study to verify this question.
Fig. 5. Linear regression shows no statistically signiﬁcant correlation between best corrected visual acuity (BCVA) in the logarithm of minimal angle resolution (logMAR) and
glycated hemoglobin (HbA1c) preoperatively (p ¼ 0.57), at Week 1 (p ¼ 0.39), in Week 2 (p ¼ 0.94), and Week 4 (p ¼ 0.91).
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diabeticpatientswithout retinopathywereasgoodas those innormal
controls for up to 4 weeks after small incision phacoemulsiﬁcation
cataract surgery. The visual outcomes andCRTchanges in the diabetic
without retinopathy patients were also not related to the level of
preoperative HbA1c during this period. Therefore, the short-term
postcataract surgery visual recovery in diabetic patients without
retinopathy may not be different from the nondiabetic group.
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